AZ And Boehringer Move Into Phase III With Rival Next-Gen CKD Drugs

 
• By Andrew McConaghie
Kidney
Chronic kidney disease is estimated to affect around 850 million people worldwide • Source: Shutterstock

More from Clinical Trials

More from R&D